INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Pharmaceutical companies
Back to Newsroom
🏢Organization Dossier

Pharmaceutical companies

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

9 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
National Governance & Policy Just now (03:52 PM IST)

Rajnath Singh Urges Wider Export Push for Indigenous Warships as Local Content Tops 75%

Defence Minister Rajnath Singh has called for a stronger export strategy for India’s indigenous warships, saying domestic content in naval platforms has now crossed 75%. He made the remarks at the second edition of the Indian Navy’s three-day biannual Commanders’ Conference 2026, underscoring the government’s push to turn naval shipbuilding into a global industrial strength.

By RDU Global Wire6 min read
Global Markets & Equities13 Nov 2026, 02:00 PM IST

Pfizer Secures $1.5 Billion Blackstone Backing to Advance Weight-Loss Drug Push

Pfizer has struck a financing agreement with Blackstone worth up to $1.5 billion to support development of its obesity-drug program, according to reports. The deal underscores how major pharmaceutical companies are increasingly leaning on private capital to help fund high-cost, high-risk drug pipelines as competition intensifies in the booming weight-loss market.

5 min readRead →
Healthcare, Pharma & Life Sciences10 Oct 2026, 11:02 AM IST

GST Council Allows Pharma Firms to Claim Input Tax Credit on Free Samples, Expired Goods from FY28

The GST Council has approved a significant relief for pharmaceutical companies, allowing them to claim input tax credit on free samples and on goods destroyed after expiry, with the changes set to take effect from the next fiscal year. The move is expected to ease a long-standing tax burden on drug makers and align GST treatment more closely with the practical realities of pharmaceutical distribution and inventory management.

6 min readRead →
Healthcare, Pharma & Life Sciences10 Oct 2026, 04:12 AM IST

GST Council Allows Pharma Firms to Claim Input Tax Credit on Free Samples, Expired Goods from FY28

The GST Council has approved a significant relief for pharmaceutical companies, allowing them to claim input tax credit on free samples and goods destroyed after expiry, effective from the next fiscal year. The move is expected to ease a long-standing tax burden on drugmakers and align GST treatment more closely with business realities in the sector.

5 min readRead →
Global Health & Biotech04 Oct 2026, 08:22 AM IST

Novartis Agrees to Up to $7.8 Billion mRNA Deal With China’s Abogen

Novartis has struck a licensing and development agreement with Chinese biotech Abogen Biosciences that could be worth as much as $7.8 billion, underscoring the Swiss drugmaker’s push into next-generation cancer therapies. The deal centers on an mRNA-encoded T-cell engager, a highly targeted approach that has drawn intense interest from large pharmaceutical companies seeking to replenish pipelines and deepen exposure to innovative Chinese science.

6 min readRead →
Macro Economy & Fiscal Policy27 Oct 2026, 08:00 PM IST

Cipla Q2 Profit Drops 35% to Rs 878 Crore as North America Weakness Weighs on Revenue

Cipla reported a sharp 35% year-on-year decline in second-quarter net profit to Rs 878 crore, as weaker North American sales and softer operating performance dragged on earnings. Revenue fell 2% and EBITDA also declined, even as the company posted 12% growth in India and highlighted regulatory progress and a biosimilar partnership to support its pipeline.

5 min readRead →
Markets, IPOs & Wealth27 Oct 2026, 04:34 PM IST

Tech Is Pushing Healthcare Into a New Investment Cycle

From biosensors and wearables to 3D-printed skin, reconstructed organs and AI-enabled clinical trials, healthcare technology is moving beyond incremental innovation and into a structural shift. The change is reshaping how care is delivered, how drugs are tested and how investors assess the next wave of growth in health-related markets.

4 min readRead →
Macro Economy & Fiscal Policy27 Oct 2026, 08:00 AM IST

India’s Outward FDI Slips 37% in September as Loan and Guarantee Support Weakens

India’s outward foreign direct investment fell to $4.34 billion in September, down 37% from August even as it remained 14% higher than a year earlier, according to the latest monthly data. The decline was driven by a sharp drop in equity commitments and weaker guarantees, even as loans to overseas subsidiaries edged higher.

5 min readRead →
Automotive, EVs & Mobility24 Oct 2026, 05:00 PM IST

Supreme Court Says Tax Must Follow Product’s Form at Sale, Not Its End Use

The Supreme Court has ruled that tax classification must be determined by a product’s physical character at the point of sale, not by how it may ultimately be used. In a setback for the revenue department, the court dismissed appeals seeking to tax Cadila Healthcare’s GRD Powder and GRD Mix as non-alcoholic beverages at 10%.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Pharmaceutical companies: